Global/International

Lunit to Power Germany's Largest Private Radiology Network with AI Imaging

South Korea’s Lunit signs major deal to deploy its AI diagnostic software across RAD-x, enhancing radiology workflows in over 20 German locations....

Roche Launches PRO-C3 by Nordic Bioscience on cobas Analyzers

New Fibrosis Biomarker Enhances Diagnostic Capabilities for Chronic Liver Disease Across Global Labs...

Seegene Unveils CURECA™ System for Fully Automated PCR Testing

Innovative platform streamlines sample-to-result diagnostics, offering scalable, multiplexed solutions for global clinical laboratories....

Mucopolysaccharidosis Type I Market Projected for Steady Growth

DelveInsight forecasts an 8% CAGR from 2025 to 2034, driven by improved diagnostics and expanding treatment options....

Europe Embraces Health Data Sharing as Johnson & Johnson MedTech Survey Shows Rising Trust in Tech-Driven Care

Survey reveals strong public and professional confidence in digital health technologies to drive personalized treatment, surgical precision, and medical training across Europe....

Dawn Health and Merck Launch Advanced Digital Platform for Growth Disorder Management

Next-generation ecosystem enhances treatment adherence, remote monitoring, and personalized support for patients with growth hormone disorders....

SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine

Amid growing global pandemic concerns, SK bioscience partners with South Korea's national effort to advance rapid-response vaccine development against avian influenza threats....

Accuray Marks Milestone with First CyberKnife® SRS/SBRT Treatments in Austria

Innovative radiosurgery system debuts at Ordensklinikum Linz, advancing precision cancer care in the region ...

Implantica Expands RefluxStop™ Access with New Center of Excellence in Spain

Hospital Universitario Central de Asturias joins European network to offer innovative acid reflux implant as Implantica scales treatment reach across the region. ...

Boston Scientific Reports Strong 12-Month Results for FARAPULSE PFA System in Persistent Atrial Fibrillation Patients

Phase II ADVANTAGE AF trial shows 73.4% freedom from arrhythmias and high safety profile, supporting expanded use of FARAWAVE and FARAPOINT PFA catheters in treating complex AF cases....